De novo missense in TUBB3

De novo missense in TUBB3

Disease Overview

De novo missense mutations in the TUBB3 gene are rare genetic disorders characterized by spontaneous mutations affecting neuronal development and function. These mutations disrupt the formation and function of microtubules in neurons, leading to a spectrum of neurological and developmental abnormalities.

Disease Category

  • Genetic Disorder
  • Neurological Disorder
  • Neurodevelopmental Disorder

Synonyms

  • TUBB3-Related Neurogenetic Disorder
  • TUBB3 Gene Mutation Syndrome
  • Neuronal Tubulin Dysfunction Syndrome

Signs & Symptoms

Neurological and developmental manifestations include: - Congenital fibrosis of extraocular muscles (CFEOM) - Developmental delays - Intellectual disability - Peripheral neuropathy - Cortical dysplasia - Microcephaly - Hypotonia - Impaired motor coordination - Axonal guidance defects - Potential visual impairments - Potential speech and language delays - Potential seizure disorders

Causes

  • Spontaneous (de novo) missense mutations in the TUBB3 gene
  • Disruption of beta-tubulin protein structure and function
  • Impaired microtubule dynamics in neuronal cells
  • Interference with neuronal migration and development

Affected Populations

  • Rare disorder affecting all genders
  • No specific racial or ethnic predisposition
  • Typically identified in early childhood
  • Estimated prevalence: Less than 1 in 100,000 individuals

Disorders with Similar Symptoms

  • Congenital fibrosis of extraocular muscles (alternative genetic causes)
  • Charcot-Marie-Tooth disease
  • Hereditary spastic paraplegia
  • Cortical malformation syndromes
  • Neurodevelopmental disorders with motor impairments

Diagnosis

Diagnostic approach: - Comprehensive neurological examination - Detailed medical history - Genetic testing for TUBB3 mutations - Neuroimaging (MRI, CT scan) - Electromyography (EMG) - Nerve conduction studies - Ophthalmological assessments - Developmental screening

Standard Therapies

Multidisciplinary management: - Individualized physical therapy - Occupational therapy - Speech and language therapy - Special education support - Orthopedic interventions - Potential surgical corrections for eye muscle abnormalities - Symptomatic treatment of neurological complications

Clinical Trials and Studies

  • Ongoing research in genetic therapies
  • Studies exploring microtubule stabilization
  • Investigations into potential molecular interventions
  • Recommended resource: ClinicalTrials.gov

References

  • Online Mendelian Inheritance in Man (OMIM)
  • National Institutes of Health Genetic and Rare Diseases Information Center
  • Peer-reviewed genetic and neurological research publications

Programs & Resources

  • Genetic counseling services
  • Rare disease support networks
  • Patient advocacy organizations
  • Specialized neurodevelopmental clinics
  • Family support groups

Complete Report

De novo missense mutations in TUBB3 represent a complex genetic disorder with significant neurological implications. While challenging, comprehensive multidisciplinary care and ongoing research offer hope for improved understanding and management of these rare conditions.

Discard
Save
Was this article helpful?

On this page